SOLEYMANZADEH; Fariba
Patent Applications and Registrations
Patent applications and USPTO patent grants for SOLEYMANZADEH; Fariba.The latest application filed is for "heteroaromatic compounds as btk inhibitors".
- SOLEYMANZADEH; Fariba - Danbury CT
- Soleymanzadeh; Fariba - Brewster NY
| Patent | Date |
|---|---|
| Heteroaromatic Compounds As Btk Inhibitors App 20210009567 - BOSANAC; Todd ; et al. | 2021-01-14 |
| Heteroaromatic compounds as BTK inhibitors Grant 10,875,852 - Bentzien , et al. December 29, 2 | 2020-12-29 |
| Isoquinolones as BTK inhibitors Grant 10,570,118 - Bosanac , et al. Feb | 2020-02-25 |
| Heteroaromatic Compounds As Btk Inhibitors App 20200055843 - BOSANAC; Todd ; et al. | 2020-02-20 |
| Heteroaromatic Compounds As Btk Inhibitors App 20190112302 - BENTZIEN; Joerg ; et al. | 2019-04-18 |
| Heteroaromatic Compounds As Btk Inhibitors App 20190092759 - BOSANAC; Todd ; et al. | 2019-03-28 |
| Isoquinolones As Btk Inhibitors App 20190023686 - BOSANAC; Todd ; et al. | 2019-01-24 |
| Heteroaromatic compounds as BTK inhibitors Grant 10,138,229 - Bentzien , et al. Nov | 2018-11-27 |
| Heteroaromatic Compounds As Btk Inhibitors App 20180222893 - BOSANAC; Todd ; et al. | 2018-08-09 |
| Heteroaromatic compounds as BTK inhibitors Grant 9,975,882 - Bosanac , et al. May 22, 2 | 2018-05-22 |
| Heteroaromatic Compounds As Btk Inhibitors App 20180086748 - BENTZIEN; Joerg ; et al. | 2018-03-29 |
| Heteroaromatic Compounds As Btk Inhibitors App 20180030037 - BOSANAC; Todd ; et al. | 2018-02-01 |
| Heteroaromatic Compounds As Btk Inhibitors App 20170320867 - BENTZIEN; Joerg Martin ; et al. | 2017-11-09 |
| Heteroaromatic Compounds As Btk Inhibitors App 20170174663 - BOSANAC; Todd ; et al. | 2017-06-22 |
| Heteroaromatic Compounds As Btk Inhibitors App 20160031872 - BENTZIEN; Joerg Martin ; et al. | 2016-02-04 |
| Heterocyclic compounds containing an indole core Grant 9,150,577 - Boyer , et al. October 6, 2 | 2015-10-06 |
| Rho kinase inhibitors Grant 9,000,154 - Kirrane , et al. April 7, 2 | 2015-04-07 |
| Soluble guanylate cyclase activators Grant 8,815,857 - Bosanac , et al. August 26, 2 | 2014-08-26 |
| Rho kinase inhibitors Grant 8,697,911 - Cook , et al. April 15, 2 | 2014-04-15 |
| Heteroaromatic Compounds As Btk Inhibitors App 20140045813 - BENTZIEN; Joerg Martin ; et al. | 2014-02-13 |
| Soluble Guanylate Cyclase Activators App 20130203729 - BOSANAC; Todd ; et al. | 2013-08-08 |
| Heterocyclic Compounds Containing An Indole Core App 20130109679 - Boyer; Stephen James ; et al. | 2013-05-02 |
| Rho Kinase Inhibitors App 20120270868 - KIRRANE; Thomas Martin ; et al. | 2012-10-25 |
| Urotensin II receptor antagonists Grant 8,258,301 - Cook , et al. September 4, 2 | 2012-09-04 |
| Rho Kinase Inhibitors App 20120165322 - Cook; Brian Nicholas ; et al. | 2012-06-28 |
| Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors App 20110118262 - Bentzien; Joerg Martin ; et al. | 2011-05-19 |
| Urotensin Ii Receptor Antagonists App 20100121051 - Cook; Brian Nicholas ; et al. | 2010-05-13 |
| Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same App 20090111791 - De Lombaert; Stephane ; et al. | 2009-04-30 |
| Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors App 20090099184 - Delombaert; Stephane ; et al. | 2009-04-16 |
| N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors App 20080280904 - Eldrup; Anne Bettina ; et al. | 2008-11-13 |
| Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same App 20060276515 - Cywin; Charles Lawrence ; et al. | 2006-12-07 |
| Heterocyclic compounds Grant 7,115,644 - Barbosa, Jr. , et al. October 3, 2 | 2006-10-03 |
| Tec kinase inhibitors App 20050209284 - Bentzien, Joerg Martin ; et al. | 2005-09-22 |
| Heterocyclic compounds App 20040192748 - Barbosa, Antonio Jose del Moral JR. ; et al. | 2004-09-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 